Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 16, 2013

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Gastrointestinal Neoplasms
Interventions
BEHAVIORAL

Questionnaire

"Completion of 3 questionnaires at baseline and at final visit about quality of life, and 1 questionnaire about symptoms, diagnosis, treatment, prognosis, and patient's relationship with caregivers. These will take about 35-50 minutes to complete.~Completion of 3 quality of life questionnaires every 3 months for 1 year."

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT01946854 - Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei | Biotech Hunter | Biotech Hunter